Last reviewed · How we verify

NCT05297500

Determination of SpO2 and PR Accuracy Specifications at Rest (71Ag_Vital-0031)

Active, enrolled Last updated 24 November 2025
What this trial tests

trial testing Pulse oximeter in Hypoxia in 12 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
23 March 2022
Primary endpoint
28 March 2022
29 October 2026

Quick facts

Lead sponsorNihon Kohden
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment12
Start date23 March 2022
Primary completion28 March 2022
Estimated completion29 October 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Nihon Kohden — full company profile →

Who can join

Adults 18 to 50, any sex, with Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pulse oximeter

Trials testing the same drug.

Other recruiting trials for Hypoxia

Currently open trials in the same condition.

Other Nihon Kohden trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05297500.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing